Pharmacoeconomics of three therapeutic schemes for anti-tuberculosis therapy induced liver injury in China

Pharmacoeconomics of three therapeutic schemes for anti-tuberculosis therapy induced liver injury in China

To evaluate the pharmacoeconomics of three therapeutic schemes in treating anti-tuberluosis therapy -induced liver injury (anti-TB DILI).

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Open medicine (Warsaw, Poland) Poland), 2018-01, Vol.13 (1), p.53-63
Hauptverfasser: Chen, Yu, Ye, Peng, Ren, Chongwu, Ren, Pengfei, Ma, Zheng, Zhang, Lin, Zhou, Wenliang, Jiang, Changjie
Format: Artikel
Sprache:eng
Schlagworte:
Anti-TB DILI
Cost analysis
Cost-effectiveness analysis
Decision trees analysis
Drug therapy
Liver
Pharmacoeconomics
Prospective
Regular
Tuberculosis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To evaluate the pharmacoeconomics of three therapeutic schemes in treating anti-tuberluosis therapy -induced liver injury (anti-TB DILI).
ISSN:2391-5463
2391-5463
DOI:10.1515/med-2018-0010